1887

Abstract

SUMMARY

Amongst 778 yeasts isolated from clinical specimens and tested for sensitivity to 5-fluorocytosine, 4.1 per cent. had minimum inhibitory concentrations of 31 μg of 5FC per ml, or more, a lower percentage of primary resistance than in some reported series. Resistance was found in 4.5 per cent. of , 0.7 per cent. of and 5.6 per cent. of . The minimum fungicidal concentrations for the resistant candida isolates greatly exceeded the minimum inhibitory concentrations, and some yeasts with low minimum inhibitory concentrations contained small numbers of highly resistant organisms.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-6-3-315
1973-08-01
2022-01-27
Loading full text...

Full text loading...

/deliver/fulltext/jmm/6/3/medmicro-6-3-315.html?itemId=/content/journal/jmm/10.1099/00222615-6-3-315&mimeType=html&fmt=ahah

References

  1. Davies R. R., Reeves D. S. 1971; 5-Fluorocytosine and urinary candidiasis. Br. Med. J 1:577
    [Google Scholar]
  2. Grunberg E., Prince H. N., Utz J. P. 1967; Observations on the activity of two newer anti-fungal agents, saramycetin (X-5079C) and 5-fluorocytosine. Proc. Vth. Internat. Congr. Chemotherapy, Wien 4:69
    [Google Scholar]
  3. Holt R. J., Newman R. L. 1972; Urinary candidiasis after renal transplantation. Br. Med. J 2:714
    [Google Scholar]
  4. Lodder J. 1970; The yeasts. 2nd ed Amsterdam and London
    [Google Scholar]
  5. Louria D. B., Blevins Anne, Armstrong D., Burdick R., Lieberman P. 1967; Fungemia caused by “ nonpathogenic ” yeasts. Archs Intern. Med 119:247
    [Google Scholar]
  6. Marks M. I., Eickhoff T. C. 1971; Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrob. Agents Chemother 1970 p 491
    [Google Scholar]
  7. Marks M. I., Langston Claire, Eickhoff T. C. 1970; Torulopsis glabrata—an opportunistic pathogen in man. New Engl. J. Med 283:1131
    [Google Scholar]
  8. Marks M. I., Steer P., Eickhoff T. C. 1971; In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine and clotrimazole (Bay 5097). Appl. Microbiol 22:93
    [Google Scholar]
  9. McGill P. E., Sequira R., Jindani A., Nguli E. T., Forrester A. T. T., Fulton W. F. M. 1969; 5-Fluorocytosine in the treatment of cryptococcal meningitis. E. Afr. Med. J 46:663
    [Google Scholar]
  10. Record C. O., Skinner J. M., Sleight P., Speller D. C. E. 1971; Candida endocarditis treated with 5-fluorocytosine. Br. Med. J 1:262
    [Google Scholar]
  11. Richards A. B., Jones B. R., Whitwell J., Clayton Yvonne M. 1969; Corneal and intra-ocular infection by Candida albicans treated with 5-fluorocytosine. Trans. Ophthal. Soc., U,. K 89:867
    [Google Scholar]
  12. Richart R., Dammin G. J. 1960; Candida tropicalis as a pathogen for man. New Engl. J. Med 263:474
    [Google Scholar]
  13. Scholer H. J. 1968; Chemotherapie von Mykosen der inneren Organe. Schweiz, med. Wschr 98:602
    [Google Scholar]
  14. Scholer H. J. 1970; Antimykoticum 5-fluorocytosin. Mykosen 13:179
    [Google Scholar]
  15. Schönebeck J. 1971; 5-Fluorocytosine treatment of candidosis of the urinary tract and Candida infection localised elsewhere. Proc. Congr. Int. Soc. Human and Animal Mycol., Paris p 299
    [Google Scholar]
  16. Shadomy S. 1969; In vitro studies with 5-fluorocytosine. Appl. Microbiol 17:871
    [Google Scholar]
  17. Shadomy S. 1970; Further in vitro studies with 5-fluorocytosine. Infect. Immun 2:484
    [Google Scholar]
  18. Steer P. L., Marks M. I., Klite P. D., Eickhoff T. C. 1972; 5-Fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann. Intern. Med 76:15
    [Google Scholar]
  19. Taschdjian Claire L., Burchall J. J., Kozinn P. J. 1960; Rapid identification of Candida albicans by filamentation on serum and serum substitutes. J. Dis. Child 99:212
    [Google Scholar]
  20. Tassel D., Madoff M. A. 1968; Treatment of Candida sepsis and cryptococcus meningitis with 5-fluorocytosine. J. Am. Med. Ass 206:830
    [Google Scholar]
  21. Utz J. P. 1972; Flucytosine. New Engl. J. Med 286:777
    [Google Scholar]
  22. Utz J. P., Tynes B. S., Shadomy H. J., Duma R. J., Kannan M. M., Mason K. N. 1969; 5-Fluorocytosine in human cryptococcosis. Antimicrob. Agents Chemother 1968 p 344
    [Google Scholar]
  23. Webb A. J., Speller D. C. E., Buckler K. G. 1970; Torulopsis glabrata septicaemia treated with 5-fluorocytosine. Lancet 1:839
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-6-3-315
Loading
/content/journal/jmm/10.1099/00222615-6-3-315
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error